Our participation in Biofabrication Conference
What is the Biofabrication Conference?
From 17 to 20 September 2023 we flew to Saskatoon (Canada) to take part in the Biofabrication Conference 2023, the international conference on innovations in biomedical 3D printing.
Electrospider at Biofabrication Conference
For our team it was an opportunity to get in touch with the international biofabrication scene and to present to the major players in the field all the potential of Electrospider, the first 3D biostampante in the world.
Furthermore, Ginevra Pegollo, Biomedical R&D Engineer, was the protagonist of the speechElectrospider: a novel bioprinting ecosystem fo biofabrication scale-up of tissues and organs“.
The event's topics
It was a fantastic experience, in an innovative and stimulating environment where it was possible to exchange experiences, discoveries and new approaches with medical researchers and engineers. In particular, we discussed innovation in the world of biofabrication, with focus on biomaterials and bioinks, biofabrication and modelling technologies and machine learning.
_
Bio3Dprinting is the owner patents that protect the offered technology at national (IT10201800005065), international (WO2019IB53625) and european level (EP20190727513).
Related posts

Con Bio3DPrinting la stampa 3D entra nella chirurgia pediatrica ad alta complessità
Realizzato un innovativo modello anatomico tridimensionale di un fegato utilizzato per la pianificazione di un delicato intervento chirurgico in uno dei principali ospedali pediatrici italiani.

Il futuro di Electrospider – Intervista ad Aurora De Acutis, CEO di Bio3DPrinting
In questa intervista Aurora De Acutis racconta quali sono le attuali applicazioni di Electrospider e la sua visione futura dei trapianti con tessuti e organi biostampati.

Electrospider realizza un modello tracheale biomimetico
La biostampa 3D segna un nuovo passo verso la medicina rigenerativa